BRAINSTORM CELL THERAPEUTICS INC
For the period ended Sep 30, 2024. Filed Nov 14, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 14, 2024
BCLI$1.14-7.3%Stored close · as of Jul 8, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
The following documents are filed as exhibits to this report:
| | | | | | | Incorporated by Reference Herein | | ||||
| ExhibitNumber | Description | Filed (or Furnished) with this Form 10-Q | Form | Exhibit & File No. | Date Filed | ||||||
| | | | | | | | | | | | |
| 3.1 | | Certificate of Incorporation of Brainstorm Cell Therapeutics Inc. | | | | Definitive Schedule 14A | | Appendix B File No. 333-61610 | | November 20, 2006 | |
| 3.2 | | Certificate of Amendment of Certificate of Incorporation of Brainstorm Cell Therapeutics Inc., dated September 15, 2014. | | | | Form 8-K | | Exhibit 3.1 File No. 000-54365 | | September 16, 2014 | |
| 3.3 | | Certificate of Amendment of Certificate of Incorporation of Brainstorm Cell Therapeutics Inc., dated August 31, 2015. | | | | Form 8-K | | Exhibit 3.1 File No. 001-366641 | | September 4, 2015 | |
| 3.4 | | Certificate of Amendment of Certificate of Incorporation of Brainstorm Cell Therapeutics Inc., dated September 16, 2024. | | | | Form 8-K | | Exhibit 3.1 File No. 001-366641 | | September 16, 2024 | |
| 3.5 | | Certificate of Amendment of Certificate of Incorporation of Brainstorm Cell Therapeutics Inc., dated September 30, 2024. | | | | Form 8-K | | Exhibit 3.1 File No. 001-366641. | | October 1, 2024 | |
| 3.5 | | ByLaws of Brainstorm Cell Therapeutics Inc. | | | | Definitive Schedule 14A | | Appendix C File No. 333-61610 | | November 20, 2006 | |
| 3.6 | | Amendment No. 1 to ByLaws of Brainstorm Cell Therapeutics Inc., dated as of March 21, 2007. | | | | Form 8-K | | Exhibit 3.1 File No. 333-61610 | | March 27, 2007 | |
| 10.1¥ | | Amendment No. 4 to the Brainstorm Cell Therapeutics Inc. 2014 Stock Incentive Plan | | | | Form 8-K | | Exhibit 10.5 File No. 001-36641 | | September 16, 2024 | |
| 10.2¥ | | Amendment No. 4 to Brainstorm Cell Therapeutics Inc. 2014 Global Share Option Plan | | | | Form 8-K | | Exhibit 10.10 File No. 001-36641 | | September 16, 2024 | |
| 31.1 | | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | * | | | | | | | |
| 31.2 | | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | | * | | | | | | | |
| 32.1 | | Certification of Principal Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | ‡ | | | | | | | |
| 32.2 | | Certification of Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | | ‡ | | | | | | | |
| 101.INS | | XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document. | | * | | | | | | | |
| 101.SCH | | Inline XBRL Taxonomy Extension Schema Document | | * | | | | | | | |
| 101.CAL | | Inline XBRL Taxonomy Extension Calculation Linkbase Document | | * | | | | | | | |
| 101.DEF | | Inline XBRL Taxonomy Extension Definition Linkbase Document | | * | | | | | | | |
| 101.LAB | | Inline XBRL Taxonomy Extension Label Linkbase Document | | * | | | | | | | |
| 101.PRE | | Inline XBRL Taxonomy Extension Presentation Linkbase Document | | * | | | | | | | |
| 104 | | Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101) | | * | | | | | | | |
*Filed herewith
‡Furnished herewith
¥Indicates a management contract or any compensatory plan, contract or arrangement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.